Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-05T16:32:26.875Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of Renal Enzymes to Evaluate Nephrotoxicity in Lithium Treated Patients

Published online by Cambridge University Press:  29 January 2018

Michael J. Garvey ,
V. B. Tuason ,
Charles H. Blomquist  and
Sutaeg Hwang
Michael J. Garvey
Affiliation:
Department of Psychiatry
V. B. Tuason
Affiliation:
Department of Psychiatry
Charles H. Blomquist
Affiliation:
Department of Obstetrics and Gynecology
Sutaeg Hwang
Affiliation:
Department of Psychiatry University of Minnesota, St Paul-Ramsey Medical Center, 640 Jackson Street, St Paul, Minnesota 55101, USA
Get access Rights & Permissions [Opens in a new window]

Summary

N-acetyl-β-glucosaminadase (NAG) is a renal enzyme which is an early, sensitive and reliable indicator of renal damage. NAG assays of midstream spot urines were not significantly different in a group of controls when compared to patients starting lithium for the first time, or to a group of patients who had been taking lithium for more than one year. However, a small number of lithium-treated patients may have evidence of renal damage, identifiable by NAG assay.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 141 , Issue 4 , October 1982 , pp. 420 - 422
Copyright
Copyright © Royal College of Psychiatrists, 1982 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baylis, P. H. & Heath, D. A. (1978) Water disturbances in patients treated with oral lithium carbonate. Annals of Internal Medicine, 88, 607–9.CrossRefGoogle ScholarPubMed
Bucht, G. & Wahlin, A. (1978) Impairment of renal concentrating capacity by lithium. Lancet, i, 778–9.Google Scholar
Bucht, G., Wahlin, A., Wentzel, T. & Winblad, B. (1980) Renal function and morphology in long-term lithium and combined lithium-neuroleptic treatment. Acta Medica Scandinavica, 208, 381–5.Google Scholar
Burrows, G. D., Davis, B. & Kincaid-Smith, P. (1978) Unique tubular lesion after lithium. Lancet, i, 1310.CrossRefGoogle Scholar
Cockcroft, D. W. & Gault, M. H. (1976) Prediction of creatinine clearance from serum creatinine. Nephron, 16, 31–41.Google Scholar
Dance, N., Price, R. G., Robinson, D. & Stirling, J. L. (1967) β-Galactosidase, β-glucosidase, and N-acetyl-β-glucosaminidase in human kidney. Clinical Chimica Acta, 24, 189–97.Google Scholar
Dance, N., Price, R. G. (1970) The excretion of N-acetyl-β-glucosaminidase and β-galactosidase by patients with renal disease. Clinical Chimica Acta, 27, 87–92.Google Scholar
Depaulo, J. R., Correa, E. I. & Sapir, P. G. (1981) Renal glomerular function and long-term lithium therapy. American Journal of Psychiatry, 138, 324–7.Google Scholar
Ellis, B. G. & Price, R. G. (1973) Urinary enzymes and the detection of kidney damage in the dog. Biochemical Society Transactions, 1, 995–7.Google Scholar
Hansen, H. E., Hestbech, J., Olsen, S. & Amdisen, A. (1977) Renal function and renal pathology in patients with lithium-induced impairment of renal concentrating ability. Proceedings of European Dialysis and Transplant Association (London), 14, 518–27.Google Scholar
Hansen, H. E. (1981) Renal toxicity of lithium. Drugs, 22, 461–76.Google Scholar
Hestbech, J., Hansen, H. E., Amdisen, A. & Olsen, S. (1977) Chronic renal lesions following long-term treatment with lithium. Kidney International, 12, 205–13.Google Scholar
Kincaid-Smith, P., Burrows, G. D., Davies, B. M., Holwill, B., Walter, M. & Walker, R. G. (1979) Renal-biopsy findings in lithium and prelithium patients. Lancet, 2, 700–1.Google Scholar
Jenner, F. A. (1979) Lithium and the question of kidney damage. Archives of General Psychiatry, 36, 888–90.Google Scholar
Patel, V., Luft, F. C., Yum, M. N., Patel, B., Zeman, W. & Kleit, S. A. (1975) Enzymuria in gentamycin-induced kidney damage. Antimicrobial Agents Chemotherapy, 7, 364–9.Google Scholar
Price, R. G., Dance, N., Ricards, B. & Cattell, W. R. (1970) The excretion of N-acetyl-β-glucosaminidase and β-galactosidase following surgery to the kidney. Clinical Chimica Acta, 27, 65–72.Google Scholar
Prien, R. (1980) Update on lithium. Psychopharmacology Bulletin, 16, 13–15.Google Scholar
Rafaelsen, O. J., Bolwig, T. G., Ladefoged, J. & Brun, L. (1979) Kidney function and morphology in long-term treatment. In Lithium: Controversies and Unresolved Issues, (eds. Cooper, T. B., Gershon, S., Kline, N. et al). Amsterdam: Excerpta Medica.Google Scholar
Robinson, D., Price, R. C. & Dance, N. (1967) Rat-urine glycosidases and kidney damage. Biochemical Journal, 102, 533–8.Google Scholar
Rowe, J. W., Audres, R., Tobin, J. D., Norrs, A. H. & Shock, N. W. (1976) Age adjusted standards for creatinine clearance. Annals of Internal Medicine, 84, 567–9.Google Scholar
Tucker, S. M., Boyd, P. J. R., Thompson, A. E. & Price, R. G. (1975) Automated assay of N-acetyl-β-glucosaminadase in normal and pathological human urine. Clinical Chimica Acta, 62, 333–9.Google Scholar
Wellwood, J. M., Ellis, B. G., Price, R. G. et al (1975a) Urinary N-acetyl-β-D-glucosaminadase activities in patients with renal disease. British Medical Journal, iii, 408–11.Google Scholar
Wellwood, J. M., Simpson, P. M., Tighe, J. R. & Thompson, A. E. (1975b) Evidence of gentamycin nephrotoxicity in patients with renal allografts. British Medical Journal, iii, 278–81.Google Scholar
Wellwood, J. M., Lovell, D., Thompson, A. E. & Tighe, J. R. (1976a) Renal damage caused by gentamycin: A study of the effects on renal morphology and urinary enzyme excretion. Journal of Pathology, 118, 171–82.Google Scholar
Wellwood, J. M., Price, R. G., Ellis, B. G. & Thompson, A. E. (1976b) A note on the practical aspects of the N-acetyl-β-glucosaminadase in human urine. Clinical Chimica Acta, 69, 85–91.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.